OncoZenge AB (publ) (ONCOZ.ST)
SEK 3.97
(4.34%)
SEK 3.97
(4.34%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -862.99 Thousand SEK | -95470.21% |
| 2022 | -903.00 SEK | 1.2% |
| 2021 | -914.00 SEK | 83.42% |
| 2020 | -5513.00 SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | -720.99 Thousand SEK | 16.45% |
| 2024 Q2 | -288 Thousand SEK | 100.0% |
| 2023 Q1 | -965.00 SEK | -6.87% |
| 2023 Q4 | -862.99 Thousand SEK | -100248.72% |
| 2023 Q2 | - SEK | 100.0% |
| 2023 FY | -862.99 Thousand SEK | -95470.21% |
| 2023 Q3 | -860.00 SEK | 0.0% |
| 2022 FY | -903.00 SEK | 1.2% |
| 2022 Q2 | -1.92 Million SEK | -71.5% |
| 2022 Q4 | -903.00 SEK | 99.83% |
| 2022 Q1 | -1.12 Million SEK | -22.73% |
| 2022 Q3 | -540 Thousand SEK | 71.96% |
| 2021 Q2 | -351 Thousand SEK | 95.01% |
| 2021 FY | -914.00 SEK | 83.42% |
| 2021 Q4 | -914.99 Thousand SEK | -109.38% |
| 2021 Q3 | -437 Thousand SEK | -24.5% |
| 2021 Q1 | -7.04 Million SEK | 0.0% |
| 2020 FY | -5513.00 SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | 2.00 SEK | 43150050.0% |
| Ziccum AB (publ) | -4.18 Million SEK | 79.398% |
| Modus Therapeutics Holding AB (publ) | - SEK | Infinity% |
| BioArctic AB (publ) | - SEK | Infinity% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 87.906% |
| Mendus AB (publ) | - SEK | Infinity% |
| Genovis AB (publ.) | 14.9 Million SEK | 105.79% |
| Intervacc AB (publ) | 10.48 Million SEK | 108.232% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | Infinity% |
| Active Biotech AB (publ) | -2500.00 SEK | -34419.96% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 102.45% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | 109.517% |
| Aptahem AB (publ) | - SEK | Infinity% |
| Vicore Pharma Holding AB (publ) | - SEK | Infinity% |
| Kancera AB (publ) | -1950.00 SEK | -44156.359% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | 127.397% |
| Saniona AB (publ) | 1.00 SEK | 86300000.0% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 46.925% |
| Biovica International AB (publ) | 2.19 Million SEK | 139.245% |
| Spago Nanomedical AB (publ) | 1.00 SEK | 86300000.0% |
| AcouSort AB (publ) | 2.08 Million SEK | 141.49% |
| Xintela AB (publ) | 398 Thousand SEK | 316.834% |
| Abliva AB (publ) | - SEK | Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | 223.286% |
| Karolinska Development AB (publ) | - SEK | Infinity% |
| Amniotics AB (publ) | 534 Thousand SEK | 261.61% |
| 2cureX AB (publ) | -1000.00 SEK | -86199.9% |
| CombiGene AB (publ) | -1.79 Million SEK | 52.029% |
| Asarina Pharma AB (publ) | - SEK | Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | 104.225% |
| Camurus AB (publ) | 100.95 Million SEK | 100.855% |
| Corline Biomedical AB | -3.85 Million SEK | 77.625% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | 86399.9% |
| Isofol Medical AB (publ) | - SEK | Infinity% |
| I-Tech AB | 4.28 Million SEK | 120.164% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | 108.813% |
| Cyxone AB (publ) | - SEK | Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | Infinity% |
| Biosergen AB | -4.92 Million SEK | 82.491% |
| Cantargia AB (publ) | - SEK | Infinity% |
| NextCell Pharma AB | 545.23 Thousand SEK | 258.28% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 101.971% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | -93.071% |
| Nanologica AB (publ) | 2.97 Million SEK | 129.028% |
| SynAct Pharma AB | - SEK | Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | Infinity% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | -168.726% |
| LIDDS AB (publ) | - SEK | Infinity% |
| Lipum AB (publ) | - SEK | Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | 107.286% |
| Alzinova AB (publ) | -3.27 Million SEK | 73.673% |
| Oncopeptides AB (publ) | 2.42 Million SEK | 135.588% |
| Pila Pharma AB (publ) | 1.00 SEK | 86300000.0% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | -57975.303% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | 121.393% |
| Simris Alg AB (publ) | 1.09 Million SEK | 179.102% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | 103.588% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 100.808% |
| Ascelia Pharma AB (publ) | - SEK | Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | 183.949% |